These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2943797)

  • 1. A human-human hybridoma secreting anti-HLA class II antibody.
    Effros RB; Hulette CM; Ettenger R; Dillard LC; Zeller E; Duong R; Walford RL
    J Immunol; 1986 Sep; 137(5):1599-603. PubMed ID: 2943797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
    Power DA; Gerkis V; d'Apice AJ
    Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies.
    Hosenpud JD; Shipley GD; Morris TE; Hefeneider SH; Wagner CR
    Transplantation; 1993 Feb; 55(2):405-11. PubMed ID: 7679530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of anti-DQ alloantisera correlated with DR5.
    Crepaldi T; Fasano ME; Frattasio C; Centis D; Curtoni ES; Richiardi P
    J Immunogenet; 1985 Dec; 12(6):301-8. PubMed ID: 2426368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of anticancer human monoclonal antibody--establishment of human monoclonal antibody to gastric cancer by human-mouse hybridoma].
    Liu H
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):242-4. PubMed ID: 3248478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a hybridoma-derived T cell factor that promotes the production of antibodies bearing a dominant cross-reactive idiotype(s).
    Wardzala AM; Bowen MB; Jendrisak GS; Bellone CJ
    J Mol Cell Immunol; 1986; 2(5):243-53. PubMed ID: 2978231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of functional domain structures on human DR determinants with mouse hybridoma antibody Tyn B1].
    Nagayoshi T
    Fukuoka Igaku Zasshi; 1985 Jun; 76(6):306-16. PubMed ID: 2414196
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
    Yamada K; Sachs DH; DerSimonian H
    J Immunol; 1995 Dec; 155(11):5249-56. PubMed ID: 7594537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
    Altomonte M; Pucillo C; Damante G; Maio M
    J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.